Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation

Asymmetric division can generate effector and memory CD8 + T cell precursors. Powell and colleagues show asymmetric partitioning of mTORC1 activity upon CD8 + T cell division, which results in distinct metabolic programming of daughter T cells. The asymmetric partitioning of fate-determining protein...

Full description

Saved in:
Bibliographic Details
Published inNature immunology Vol. 17; no. 6; pp. 704 - 711
Main Authors Pollizzi, Kristen N, Sun, Im-Hong, Patel, Chirag H, Lo, Ying-Chun, Oh, Min-Hee, Waickman, Adam T, Tam, Ada J, Blosser, Richard L, Wen, Jiayu, Delgoffe, Greg M, Powell, Jonathan D
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.06.2016
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1529-2908
1529-2916
1529-2916
DOI10.1038/ni.3438

Cover

More Information
Summary:Asymmetric division can generate effector and memory CD8 + T cell precursors. Powell and colleagues show asymmetric partitioning of mTORC1 activity upon CD8 + T cell division, which results in distinct metabolic programming of daughter T cells. The asymmetric partitioning of fate-determining proteins has been shown to contribute to the generation of CD8 + effector and memory T cell precursors. Here we demonstrate the asymmetric partitioning of mTORC1 activity after the activation of naive CD8 + T cells. This results in the generation of two daughter T cells, one of which shows increased mTORC1 activity, increased glycolytic activity and increased expression of effector molecules. The other daughter T cell has relatively low mTORC1 activity and increased lipid metabolism, expresses increased amounts of anti-apoptotic molecules and subsequently displays enhanced long-term survival. Mechanistically, we demonstrate a link between T cell antigen receptor (TCR)-induced asymmetric expression of amino acid transporters and RagC-mediated translocation of mTOR to the lysosomes. Overall, our data provide important insight into how mTORC1-mediated metabolic reprogramming affects the fate decisions of T cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Present Address: Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Present Address: Experimental Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Present Address: Department of Research Oncology, MedImmune LLC, Gaithersburg, Maryland, USA.
Contributed equally and should be considered co-first authors
ISSN:1529-2908
1529-2916
1529-2916
DOI:10.1038/ni.3438